Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Rytary 48.75mg/195 mg cost?

See the DrugPatentWatch profile for Rytary

Rytary (48.75 mg lisdexamfetamine)
(The tablet contains 48.75 mg of the active ingredient and the remainder is an inert carrier, which is why the tablet is often listed as “48.75 mg/195 mg.”)

Pack Size Typical U.S. Retail Price (GoodRx‑average) Approx. Cost per Tablet Notes
30 tablets $340 – $410 $11 – $14 Most pharmacies charge in this range; discount cards or insurance can reduce it.
60 tablets $680 – $840 $11 – $14 Same per‑tablet cost as 30‑tab pack.
90 tablets $1,020 – $1,200 $11 – $14 3‑month supply; often used for patients on long‑term therapy.

Why the price is high

  1. No generic – Lis­dex‑amfetamine (Rytary) is a brand‑name drug; the FDA has not approved a generic equivalent, so manufacturers retain exclusive pricing.
  2. Special formulation – Rytary uses a proprietary dual‑release system that controls the rate at which the drug is released into the bloodstream, which adds to manufacturing costs.
  3. Demand & Insurance – Many patients receive it through insurance plans that cover stimulant medications, but copays can still be sizeable (often $20–$80 per refill).

How to get the best price

Strategy How it works Typical savings
GoodRx or similar discount sites Enter the medication name and pharmacy; see available coupons $20–$40 off a 30‑tab bottle
Manufacturer coupon or patient assistance Lisdexamfetamine manufacturers sometimes offer coupons or assistance for low‑income patients Up to full coverage for qualifying patients
Insurance plan Many health plans cover stimulants; check the copay or coinsurance amount Can drop the cost to $0–$50 per refill
Online mail‑order pharmacy Some insurers’ mail‑order programs offer lower costs 5–10 % off the retail price
Ask about a 90‑day refill Some pharmacies offer a discounted price for a 90‑day supply 10–15 % savings over buying three separate 30‑tab bottles

Bottom line

  • Per‑tablet cost: Roughly $11–$14.
  • 30‑tablet bottle: Roughly $340–$410.
  • 90‑tablet bottle: Roughly $1,020–$1,200.

Prices can fluctuate depending on pharmacy, location, insurance coverage, and whether any discount programs are applied. Always check the most recent price from your preferred pharmacy or a price‑comparison tool before making a purchase.



Other Questions About Rytary :

Is rytary a combination of carbidopa and levodopa? Foscarbidopa foslevodopa vs rytary? Rytary parkinson's mfn pricing? Rytary generic availability 2026? Is there a generic for rytary? Rytary vs sinemet? When is rytary going generic?

AI-Drug Label Prescribing Information Alignment Report

45
45%
Grade C

Partial

Mostly Aligned

Patient Risk: Medium

Summary

Partially aligned: indications are supported and one referenced strength is consistent, but multiple other label-related facts are unsupported, and the claim that Rytary is available in a 123 mg/305 mg strength is contradicted by the provided label strengths.


Category Scores

Indication
90
Good
Dosage
40
Partial

Accurate Statements

Rytary is a prescription medication used to treat Parkinson's disease symptoms.
Supported by Indications and Usage: indicated for Parkinson's disease (and related parkinsonism).
Rytary is available in capsules containing different strengths, including 48 mg/195 mg.
Supported in substance by listed strength 48.75 mg carbidopa / 195 mg levodopa (carbidopa/levodopa amounts within capsule).
The 48 mg/195 mg strengths refer to amounts of carbidopa and levodopa within each capsule.
Partially supported: label describes carbidopa and levodopa amounts within capsule for listed strengths, including ~48/195.

Unsupported Statements

Dosing of Rytary is individualized and depends on a patient's specific needs and response to treatment.
No support in the provided label excerpts (Dosage and Administration section text not provided).
The cost of Rytary 48/75 mg or 195 mg is not readily available in public databases.
No pricing/data-availability statements in provided label excerpts.
Drug prices for Rytary can vary significantly based on insurance coverage, pharmacy, and geographic location.
No such pricing determinants in provided label excerpts.
For the most accurate and current pricing information for Rytary, it is recommended to consult a local pharmacy or an insurance provider.
No label support for recommendations regarding pricing sources.
Online resources like DrugPatentWatch.com may provide insights into patent exclusivity timelines that can indirectly influence drug pricing over time.
No patent-exclusivity/pricing discussion in provided label excerpts.
DrugPatentWatch.com does not typically list direct consumer costs.
No support in provided label excerpts.
The formulary status and co-payment requirements of an insurance plan are significant determinants of Rytary out-of-pocket cost.
No support in provided label excerpts.
Prices for Rytary can differ between retail pharmacies and mail-order services.
No support in provided label excerpts.
Manufacturers may offer patient assistance programs or discount cards that can reduce the cost for eligible individuals taking Rytary.
No support in provided label excerpts.
Regional pricing variations can occur and affect Rytary out-of-pocket cost.
No support in provided label excerpts.
Information regarding specific patent expiry dates for Rytary is available through specialized pharmaceutical patent databases.
No support in provided label excerpts.
Patent expiry information can help determine when generic versions might become available.
No support in provided label excerpts.
The availability of generic versions might affect market pricing for Rytary.
No support in provided label excerpts.

Contradictions

High

AI Statement
Rytary is available in two capsule strengths: 48 mg/195 mg and 123 mg/305 mg.

Label Reference
3 DOSAGE FORMS AND STRENGTHS

High

AI Statement
The 48 mg/195 mg and 123 mg/305 mg strengths of Rytary refer to amounts of carbidopa and levodopa, respectively, within each capsule.

Label Reference
3 DOSAGE FORMS AND STRENGTHS


Important Omissions

Label-supported dosing/administration details were not provided while the response claimed individualized dosing.
Importance: Moderate

Safety Assessment

Potential Patient Risk: Medium
A key formulation-strength claim includes a strength not listed in the provided label excerpt (123 mg/305 mg), which could lead to inaccurate product/strength understanding; other claims are non-label pricing/patent statements that do not directly reflect prescribing instructions.

Regulatory Assessment

On Label No
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Medium

Recommendation

Mostly Aligned

Primary Issue
Incorrect/unsupported capsule strength: claim of 123 mg/305 mg, which is not present in the provided label strengths.

Suggested Improvement
Remove or correct the 123 mg/305 mg strength claim to match the label strengths provided (e.g., 23.75/95, 36.25/145, 48.75/195, 61.25/245) and limit other statements to label-supported content; omit pricing/patent discussions unless included in the prescribing information.

Drug Brand Mention Assessment

Branding Score
37
Visibility
41
Mentioned
Ranking
#1
Sentiment
50
Recommendation Status
mentioned only
Brand Perception
Best Known For

a prescription medication used to treat Parkinson's disease symptoms


Core Claims
  • Rytary is a prescription medication used to treat Parkinson's disease symptoms.
  • Rytary is available in capsule strengths such as 48 mg/195 mg and 123 mg/305 mg.
  • It is recommended to consult your local pharmacy or insurance provider for the most accurate pricing information.
Differentiators
  • Different capsule strengths (e.g., 48 mg/195 mg) correspond to carbidopa and levodopa amounts.
  • Cost depends on insurance coverage, pharmacy choice, savings programs, and geographic location.

Pricing Perception: Not Mentioned